Le attuali linee guida stratificano il rischio dei pazienti con ipertensione arteriosa polmonare
(IAP) in basso, intermedio e alto (rispettivamente con mortalità a 1 anno< 5%, 5-10% e> …

Pulmonary hypertension (PH) is a severe and progressive pulmonary hemodynamic
syndrome. In the present paper we provide an overview of the pulmonary hypertension in …

La hipertensión arterial pulmonar (HAP) se caracteriza por el aumento progresivo de la
resistencia vascular pulmonar (RVP) que conduce al fallo del ventrículo derecho y puede …

This review addresses pulmonary arterial hypertension (PAH), an incurable disease that
determines high morbidity and mortality. Diagnosis is usually performed at advanced stages …

This chapter will examine the descriptive epidemiology of HHT in the UK. Worldwide,
epidemiological studies estimate the prevalence of HHT to be between 1 in 5,000 and 1 in …

Abstract Background: Cardiovascular diseases (CVDs) culminating into heart failure (HF)
are major causes of death in men and women. Prevalence and manifestation, however …

Pulmonary arterial hypertension (PAH) is a progressive, life-limiting disease, characterised
by increased pulmonary vascular resistance and right ventricular hypertrophy leading to …

Pulmonary arterial hypertension (PAH) is a devastating vasculopathy that predominates in
women and has been associated with dysregulated estrogen and serotonin signalling. Over …

Abstract L'Ipertensione Arteriosa Polmonare (IAP) è una forma rara di ipertensione
polmonare e comprende un gruppo eterogeneo di condizioni cliniche: può essere …

A hipertensão arterial pulmonar (HAP) é uma patologia que se caracteriza inicialmente por
aumento da resistência e redução gradativa do lúmen vascular pulmonar, levando ao …